About this trial
The demographic life expectancy enhancement of the past 150 years imposes an urgent challenge in Western and economically growing societies to stimulate the healthy lifespan that is lagging behind. Families surviving into exceptionally high ages (longevity) in good physical and mental health illustrate that this is physiologically possible. Such families harbor cross generational socio-genetic mechanisms that mediate healthy aging and protection from (multi)morbidity.
The purpose of our research is: to identify gene variants associated with healthy aging and protection from (multi)morbidity; to study the social-, environment- and behavioral factors of familial longevity, their role in (multi-)morbidity and its interaction with the genetic component.
Eligibility criteria
Qualifiers
Siblings of Dutch Caucasian descent age 75+ enriched for familial longevity
Individuals of Dutch Caucasian descent age 75+ who are not enriched for familial longevity
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Leiden University Medical Center
Lead sponsor
Jacobijn Gussekloo, Prof. dr.
Collaborator
Simon P. Mooijaart, Prof. dr.
Collaborator